ID   MTX-TK
AC   CVCL_B3QM
DR   Wikidata; Q110433075
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E941 ! TK [Human brain lymphoma]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=30993483; DOI=10.1007/s10147-019-01451-9;
RA   Hayano A., Takashima Y., Yamanaka R.;
RT   "Cell-type-specific sensitivity of bortezomib in the
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   Int. J. Clin. Oncol. 24:1020-1029(2019).
//
RX   PubMed=31510952; DOI=10.1186/s12885-019-6129-8; PMCID=PMC6739943;
RA   Takashima Y., Yoshimura T., Kano Y., Hayano A., Hondoh H., Ikenaka K.,
RA   Yamanaka R.;
RT   "Differential expression of N-linked oligosaccharides in
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   BMC Cancer 19:910.1-910.11(2019).
//